132 related articles for article (PubMed ID: 27983981)
21. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
[TBL] [Abstract][Full Text] [Related]
22. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
23. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
24. CUL4A as a marker and potential therapeutic target in multiple myeloma.
Yang Y; Wang S; Li J; Qi S; Zhang D
Tumour Biol; 2017 Jul; 39(7):1010428317703923. PubMed ID: 28677427
[TBL] [Abstract][Full Text] [Related]
25. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
26. CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.
Huang G-; Liu TT; Weng SW; You HL; Wei YC; Chen CH; Eng HL; Huang WT
BMC Cancer; 2017 Jun; 17(1):395. PubMed ID: 28576144
[TBL] [Abstract][Full Text] [Related]
27. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
[TBL] [Abstract][Full Text] [Related]
28. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
Shi C; Zhang Z
Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
[TBL] [Abstract][Full Text] [Related]
29. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA
Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765
[TBL] [Abstract][Full Text] [Related]
30. Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1.
Wang Z; Ji G; Wu Q; Feng S; Zhao Y; Cao Z; Tao C
Life Sci; 2018 Oct; 210():263-270. PubMed ID: 30138596
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-124 inhibits proliferation, invasion, migration and epithelial-mesenchymal transition of cervical carcinoma cells by targeting astrocyte-elevated gene-1.
Zhang X; Cai D; Meng L; Wang B
Oncol Rep; 2016 Oct; 36(4):2321-8. PubMed ID: 27571703
[TBL] [Abstract][Full Text] [Related]
32. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
33. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
34. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
35. Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT.
Liu Y; Li H; Ban Z; Nai M; Yang L; Chen Y; Xu Y
Oncol Rep; 2017 Jun; 37(6):3643-3650. PubMed ID: 28440436
[TBL] [Abstract][Full Text] [Related]
36. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
Yao J; Deng B; Zheng L; Dou L; Guo Y; Guo K
Oncol Rep; 2016 Mar; 35(3):1645-51. PubMed ID: 26706910
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
Fu X; Cui Y; Yang S; Xu Y; Zhang Z
Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
[TBL] [Abstract][Full Text] [Related]
38. miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.
Bandi V; Baluchamy S
Med Oncol; 2017 Aug; 34(8):146. PubMed ID: 28730334
[TBL] [Abstract][Full Text] [Related]
39. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
40. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
